A Study of Dibotatug in People With Bone Marrow Failure Syndromes

Full Title

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Dibotatug in Adults with Bone Marrow Failure Syndromes

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Brian Shaffer’s office at 646-608-3737.

Protocol
26-366
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
Brian Shaffer
Co-Investigators
Moneeza Walji
Diseases
Hematology › Aplastic Anemia
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07712562
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description